The overall goal of this program is to determine the basic mechanisms underlying the regulation of the physiology and pharmacology of basal ganglia amino acid and peptidergic pathways. Within this context, our interests proceed from the behavioral level to the synaptic and molecular level. We are interested in understanding the regulation of the physiological properties of the basal ganglia after selective lesions in relation to motor behavior, the neurotransmitters used in accomplishing this behavior, and the fundamental characteristics of the neurotransmitter receptors that are involved. Our specific goals are as follows: 1. Study the effects of excitotoxic lesions of GABAergic and glutamatergic connections of the basal ganglia on unit activity and motor performance in animals trained to carry out a motor task. 2. Test the hypothesis that the subthalamic nucleus is glutamatergic and is a convergence point for the regulation of striatal and pallidal output and determine whether cortical and thalamic striatal afferents differentially affect striatal neuron subpopulations. 3. Determine the kinetic properties of the GABAA, NMDA and quisqualate receptor channels and the mechanisms by which drugs and ions regulate these properties. 4. Investigate the mechanisms by which neuropeptide Y and somatostatin receptors are coupled to voltage dependent calcium channels.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS019613-10
Application #
2263647
Study Section
Special Emphasis Panel (SRC (05))
Project Start
1984-12-01
Project End
1995-11-30
Budget Start
1993-12-06
Budget End
1995-11-30
Support Year
10
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Neurology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Deng, Y P; Albin, R L; Penney, J B et al. (2004) Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. J Chem Neuroanat 27:143-64
Greenfield Jr, L John; Zaman, Shahid H; Sutherland, Margaret L et al. (2002) Mutation of the GABAA receptor M1 transmembrane proline increases GABA affinity and reduces barbiturate enhancement. Neuropharmacology 42:502-21
Greene, J G; Sheu, S S; Gross, R A et al. (1998) 3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms. Neuroscience 84:503-10
Wullner, U; Standaert, D G; Testa, C M et al. (1997) Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain. Brain Res 768:215-23
Aldridge, J W; Thompson, J F; Gilman, S (1997) Unilateral striatal lesions in the cat disrupt well-learned motor plans in a GO/NO-GO reaching task. Exp Brain Res 113:379-93
Gross, R A; Covey, D F; Ferrendelli, J A (1997) Voltage-dependent calcium channels as targets for convulsant and anticonvulsant alkyl-substituted thiobutyrolactones. J Pharmacol Exp Ther 280:686-94
Milbrandt, J C; Albin, R L; Turgeon, S M et al. (1996) GABAA receptor binding in the aging rat inferior colliculus. Neuroscience 73:449-58
Penney, J B; Standaert, D G; Testa, C M et al. (1996) Glutamate receptor genes in Parkinson's disease. Adv Neurol 69:79-86
Bazzett, T J; Falik, R C; Becker, J B et al. (1996) Chronic intrastriatal administration of quinolinic acid produces transient nocturnal hypermotility in the rat. Brain Res Bull 39:69-73
Tallaksen-Greene, S J; Albin, R L (1996) Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons. Neuroscience 75:1057-64

Showing the most recent 10 out of 151 publications